Therefore, targeting the PPP in tumor cells may provide a therapeutic strategy based on ferroptosis
Further clinical evidence also indicates that long-term therapy with exenatide may offer some degree of pancreatic -cell protection, an important consideration in slowing disease progression
Zepbound and Mounjaro are the brand names for Tirzepatide, which is a dual agonist affecting GLP-1 and glucose-dependent insulinotropic polypeptide (GIP for short)
Cannabis as a potential compound against various malignancies, legal aspects, advancement by exploiting nanotechnology and clinical trials
Ohlmeier C, Mikolajczyk R, Haverkamp W, Garbe E
Orforglipron represents a genuinely new approach to GLP-1 receptor activation